Free Newsletter
Stem cell study improves survival of ALS animals
Investigators at the University of Wisconsin have made a key breakthrough in the use of adult stem cells to treat ALS. By injecting adult stem cells modified with a growth factor into the muscles of rodents modeled with ALS, they registered a significant 28-day improvement in survival.
The research project follows a study in which investigators were able to protect motor neurons by injecting stem cells directly into the spinal cord but failed to see a corresponding improvement in survival. Their theory was that the motor neurons were failing to reconnect at the muscles and followed up with this new study to see if they could correct that.
This new approach not only increased survival but also improved the function of the diseased animals. More work will need to be done before bringing this therapeutic approach to the clinic.
- read the University of Wisconsin release
Related Articles:
New targets for ALS
Stem cell breakthrough propels research on ALS
Stem cells dramatically reduce brain damage in study
Stem cell scientist predicts health revolution
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: